Table II. Details of included cases. Details of 23 reported and two present cases.
PFS: Progression-free survival; RR: response rate; LN: lymph node; LND: lymph node dissection; F: female, M: male, SD: stable disease; PD: progressive disease; P: partial response; CCRT: concurrent chemoradiotherapy; Ipi: Ipilimumab; Nivo: Nivolumab.
